Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria (clinicaltrials.gov) - Jan 13, 2020 - P1; N=32; Not yet recruiting; Sponsor: United BioPharma; N=48 ➔ 32
Clinical • Enrollment change
|